# Therapeutic Abstention and Surveillance of Intra-epithelial Histological Lesions of High Grade Cervical CIN2 (Cervical Intraepithelial Neoplasia Grade 2). SUIVICIN

> **NCT04057924** · — · RECRUITING · sponsor: **University Hospital, Bordeaux** · enrollment: 200 (estimated)

## Conditions studied

- HPV Infection
- Cervical Cancer

## Interventions

- **OTHER:** abstention from CIN2 treatment and surveillance for at least 2 years

## Key facts

- **NCT ID:** NCT04057924
- **Lead sponsor:** University Hospital, Bordeaux
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2019-08-23
- **Primary completion:** 2029-09-01
- **Final completion:** 2029-09-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04057924

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04057924, "Therapeutic Abstention and Surveillance of Intra-epithelial Histological Lesions of High Grade Cervical CIN2 (Cervical Intraepithelial Neoplasia Grade 2). SUIVICIN". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04057924. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*